Medication guide
Saxenda is leaving the US market, with last shipments to wholesalers in late January 2027
Novo Nordisk is discontinuing Saxenda (liraglutide) in the US. Its notice says the last shipments to wholesalers take place in late January 2027, and that the decision is not about safety or quality. Generic liraglutide, the Wegovy pill and pen, and Foundayo remain available, at the cash prices below.

What changed, with dates
- Late January 2027: last Saxenda shipments to US wholesalers, per Novo Nordisk's notice to clinicians and NovoCare (both read November 20, 2026).
- Why: Novo says patient numbers kept falling as more FDA-approved options arrived, and calls it a strategic portfolio decision, not a safety or quality issue.
- Savings card: already gone. It closed to new enrollees on June 30, 2023 and its benefits ended on December 31, 2023.
- Generic: Teva announced FDA approval and US launch of a generic of Saxenda on August 28, 2025 (report).
- Help line: Novo Nordisk Customer Care Center, 1-800-727-6500.
What the FDA-approved alternatives cost today
Cash prices from each maker's own page, read November 20, 2026 unless the row says otherwise. Your prescriber picks the drug and strength.
| Drug | Self-pay price | Source |
|---|---|---|
| Wegovy pill (semaglutide) | $149 (1.5 mg), $199 (4 mg), $299 (9 mg and 25 mg) a month | Novo Nordisk |
| Wegovy pen (semaglutide) | $199 a month for a new patient's first 2 fills of 0.25 mg or 0.5 mg through Dec 31, 2026, then $349; Wegovy HD 7.2 mg $399 | Novo Nordisk |
| Foundayo pill (orforglipron) | From $149 (0.8 mg and 2.5 mg), $199 (5.5 mg), $299 (9 mg and up) a month at LillyDirect | Eli Lilly |
| Zepbound KwikPen (tirzepatide) | From $299 a month at the starting strength, up to $449 at higher doses | Eli Lillyread Nov 6, 2026 |
With commercial coverage, the Wegovy and Foundayo savings offers can bring the cost to as little as $25 a month. Eligible Medicare Part D members can pay $50 a month for Wegovy, Foundayo or Zepbound KwikPen through the Medicare GLP-1 Bridge. More detail: Wegovy pill cost, Foundayo guide, Foundayo vs Wegovy pill.
How to switch from Saxenda: what the FDA labels say
No FDA label gives a dose conversion from Saxenda. Each new drug begins at the starting dose its own label sets, then steps up on that label's schedule, so your full Saxenda dose does not carry over. The table quotes each label's starting instruction word for word, from DailyMed, read November 20, 2026. Your prescriber decides which drug you move to, where you start and how fast you step up.
| Drug | Form | The label's starting instruction |
|---|---|---|
| Wegovy pen (semaglutide) | Weekly injection | “Initiate at 0.25 mg once weekly for 4 weeks.” FDA label |
| Wegovy pill (semaglutide) | Daily tablet | “Initiate WEGOVY tablet with a dosage of 1.5 mg once daily for 30 days.” FDA label |
| Zepbound (tirzepatide) | Weekly injection | “The recommended starting dosage is 2.5 mg injected subcutaneously once weekly for 4 weeks.” FDA label |
| Foundayo (orforglipron) | Daily tablet | “Starting dosage is 0.8 mg once daily. After at least 30 days, increase dosage to 2.5 mg once daily.” FDA label |
| Saxenda (liraglutide), for reference | Daily injection | “Initiate at 0.6 mg per day for one week. In weekly intervals, increase the dose until a dose of 3 mg is reached.” FDA label |
- No overlap: each of these labels says using the drug with another GLP-1 receptor agonist is not recommended (Saxenda, Wegovy, Zepbound, Foundayo). The switch is a stop and a start; your prescriber sets both dates.
- Same drug, new maker: generic liraglutide keeps your daily shot and the Saxenda label's schedule. Ask your pharmacy what it stocks.
- Pills: the Wegovy pill and Foundayo are daily tablets, priced from $149 a month at the lowest strength in the table above.
- Compounded: compounded semaglutide and tirzepatide cost less, but the FDA says compounded drugs are not FDA-approved and it does not review them for safety, effectiveness or quality before they are marketed.
- Insurance: a new drug usually needs a new prior authorization. Ask your plan before your last Saxenda fill.
Before your last pen: a checklist
- Call your pharmacy: how much Saxenda does it hold, and does it stock generic liraglutide?
- Book your prescriber now. Bring your current dose, how long you have taken it, your results and any side effects.
- Ask your plan which GLP-1 drugs it prefers and what its prior authorization needs.
- Price both routes: your insured cost against the cash prices above.
- Get the stop and start dates in writing, so you never take two GLP-1 drugs at once.
Your options now: telehealth programs
Programs in our published order, with the price on our record. Compounded medications are not FDA-approved and are not the brand products.
- Check price at Embody
Embody
from $49/mo on a 12-month plan; $79/mo semaglutide, $129/mo tirzepatide, monthly plan
- Check price at TrimRx
TrimRx
From $179 (seller says GLP-1), from $279 (seller says GLP-1 + GIP), plan term not stated
- Check price at SnagRx
SnagRx
$59/mo semaglutide, $109/mo tirzepatide, sale price, plan term not stated
Every recorded program: the full directory.